Ira Mellman | |
---|---|
Alma mater | Oberlin College, Yale University, Rockefeller University |
Known for | endosomes |
Scientific career | |
Fields | cell biology |
Institutions | Genentech, University of California, San Francisco |
Doctoral advisor | Leon Rosenberg |
Other academic advisors | Ralph Steinman |
Ira Mellman is an American cell biologist who discovered endosomes. [1] He served as Vice President of Research Oncology at Genentech in South San Francisco, California. [2]
Mellman's work has examined the role of endocytosis in cell metabolism and human disease. He was among the first to characterize the endosomal system. Later projects include investigation of LDL cholesterol receptor internalization, cellular sorting machinery, and the cellular basis for immunity. He is an authority on the cell biological mechanisms and function of dendritic cells, the cell type responsible for initiating the immune response, an interest that dates back to his postdoctoral period at Rockefeller University in the lab of Ralph Steinman, who won the Nobel Prize in 2011 for his discovery of dendritic cells.
Mellman grew up in New York, where he lived until he enrolled at Oberlin College in Oberlin, Ohio. While in college he maintained an interest in music but focused on the rapidly expanding field of cell biology. Working with David Miller, he began to study Chlamydomonas and found that a significant amount of the cell wall consisted of extensin. [3] After leaving Oberlin, he enrolled in the graduate program at the University of California, Berkeley, but later transferred to Yale University to switch to research more applicable to people. At Yale, he studied the genetics behind vitamin B12 metabolism under the guidance of geneticist Leon Rosenberg. He became interested in endocytosis and did a postdoc with Ralph Steinman and Zanvil A. Cohn at Rockefeller University and started characterizing endosomes. [2]
He returned to Yale after completing postdoctoral work and remained there as a professor for over twenty years. During this time he was the Sterling Professor of Cell Biology & Immunobiology, chair of the Cell Biology Department, Scientific Director of the Yale Cancer Center and a member of the Ludwig Institute for Cancer Research. Mellman has served on the council of the American Society for Cell Biology, is currently on the Board of Directors of the American Association for Cancer Research, and was the editor-in-chief of the Journal of Cell Biology from 1999 to 2008. He remains active as a senior editor for the journal.
In 2007, he was recruited to Genentech as the VP of Research Oncology to replace Marc Tessier-Lavigne. There, the company is developing understanding of immunology and along that, immunotherapy. In August 2024, Roche/Genentech announced the decision to shut down its cancer immunology research department leading to the departure Mellman who has been with the company for 17 years and led the unit. [4] [5]
Mellman is a member of the United States National Academy of Sciences, [2] a Fellow of the American Academy of Arts and Sciences, and a Foreign Associate of the European Molecular Biology Organization (EMBO).
In 1976, he married Margaret Moench. The couple have three children. [6]
In December 2018, Mellman spoke at the 'Antibody Engineering and Therapeutics" conference, which took place in San Diego, California.
Endocytosis is a cellular process in which substances are brought into the cell. The material to be internalized is surrounded by an area of cell membrane, which then buds off inside the cell to form a vesicle containing the ingested materials. Endocytosis includes pinocytosis and phagocytosis. It is a form of active transport.
Endosomes are a collection of intracellular sorting organelles in eukaryotic cells. They are parts of the endocytic membrane transport pathway originating from the trans Golgi network. Molecules or ligands internalized from the plasma membrane can follow this pathway all the way to lysosomes for degradation or can be recycled back to the cell membrane in the endocytic cycle. Molecules are also transported to endosomes from the trans Golgi network and either continue to lysosomes or recycle back to the Golgi apparatus.
Ralph Marvin Steinman was a Canadian physician and medical researcher at Rockefeller University, who in 1973 discovered and named dendritic cells while working as a postdoctoral fellow in the laboratory of Zanvil A. Cohn, also at Rockefeller University. Steinman was one of the recipients of the 2011 Nobel Prize in Physiology or Medicine.
Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance and immunoediting are based on protection against development of tumors in animal systems and (ii) identification of targets for immune recognition of human cancer.
The Journal of Cell Biology is a peer-reviewed scientific journal published by Rockefeller University Press.
Zanvil Alexander Cohn was a cell biologist and immunologist who upon his death was described by The New York Times as being "in the forefront of current studies of the body's defenses against infection.", professor at Rockefeller University. There Cohn had been the Henry G. Kunkel Professor for seven years. Cohn was senior physician at the university as well as vice president for medical affairs. Until two years before his death, he also served as principal investigator of the Irvington Institute for Medical Research. Although Cohn never won the Nobel Prize, Ralph M. Steinman, with whom he ran a laboratory at Rockefeller University for many years, was named to win the 2011 Nobel Prize in Physiology or Medicine for the work on dendritic cells done in their lab, eighteen years after Cohn's death.
Robert F. Murphy is Ray and Stephanie Lane Professor of Computational Biology Emeritus and Director of the M.S. Program in Automated Science at Carnegie Mellon University. Prior to his retirement in May 2021, he was the Ray and Stephanie Lane Professor of Computational Biology as well as Professor of Biological Sciences, Biomedical Engineering, and Machine Learning. He was founding Director of the Center for Bioimage Informatics at Carnegie Mellon and founded the Joint CMU-Pitt Ph.D. Program in Computational Biology. He also founded the Computational Biology Department at Carnegie Mellon University and served as its head from 2009 to 2020.
Gillian Griffiths, FMedSci FRS is a British cell biologist and immunologist. Griffiths was one of the first to show that immune cells have specialised mechanisms of secretion, and identified proteins and mechanisms that control cytotoxic T lymphocyte secretion. Griffiths is Professor of Cell Biology and Immunology at the University of Cambridge and is the Director of the Cambridge Institute for Medical Research.
Sandra Louise Schmid is the first Chief Scientific Officer of the Chan Zuckerberg Biohub. She is a Canadian cell biologist by training; prior to her move to CZ Biohub, she was Professor and Chair of the Cell Biology Department at the University of Texas Southwestern Medical Center. Throughout her academic career, she has authored over 105 publications on the molecular mechanism and regulation of clathrin-mediated endocytosis and the structure and function of the GTPase dynamin and mechanisms governing membrane fission. She was the first to identify dynamin's key role in endocytosis. She is a co-founder of the journal Traffic and has been the Editor-in-Chief of Molecular Biology of the Cell, and the President of the American Society for Cell Biology.
Michel C. Nussenzweig is a professor and head of the Laboratory of Molecular Immunology at The Rockefeller University and a Howard Hughes Medical Institute investigator. He is a member of both the US National Academy of Medicine and the US National Academy of Sciences.
The dendritic cell-based cancer vaccine is an innovation in therapeutic strategy for cancer patients.
Peter J. Peters is a professor of nanobiology and a distinguished university professor at Maastricht University. Peters is best known for his work in electron microscopy (EM) and cellular immunology. He is the founder and director of the Institute of Nanoscopy.
Jacques Banchereau is an internationally prominent French American immunologist and molecular biologist. As of 2022, he is Chief Scientific Officer at Immunai. He was formerly professor and director of immunological sciences at the Jackson Laboratory for Genomic Medicine and also the former chief science officer, senior vice president, and DTA head of inflammation & virology at Hoffman-La Roche. He is best known for his extensive research on dendritic cells with Nobel Laureate Ralph M. Steinman. He is the fifth most cited immunologist ranked by Times Higher Education's report.
Sebastian Amigorena is an Argentine immunologist and a Team Leader at the Institut Curie.
Jean Gruenberg is a Swiss biologist, and a professor at the University of Geneva. His research in the fields of cell biology and biochemistry has significantly contributed to a better understanding of the molecular mechanisms involved in the intracellular traffic within eukaryotic cells, more especially in the endolysosomal pathway.
Bradlee L. Heckmann is an American biologist, pharmacologist. Heckmann holds academic appointments as a neuroimmunologist at the Byrd Alzheimer's Center and USF Health Neuroscience Institute and is assistant professor in molecular medicine at the USF Health Morsani College of Medicine. Heckmann's research has been focused on understanding the regulation of inflammatory and metabolic processes in the central nervous system, with particular emphasis on neurodegenerative diseases including Alzheimer's disease and the role of the autophagy machinery in this setting.
David G. Drubin is an American biologist, academic, and researcher. He is a Distinguished Professor of Cell and Developmental Biology at the University of California, Berkeley where he holds the Ernette Comby Chair in Microbiology.
Jonathan C. Kagan is an American immunologist and the Marian R. Neutra, Ph.D. Professor of Pediatrics at Harvard Medical School. He is also the director of Basic Research and Shwachman Chair in Gastroenterology at Boston Children's Hospital. Kagan is a world leader in defining the molecular basis of innate immunity and inflammation.
Gia Voeltz is an American cell biologist. She is a professor of Molecular, Cellular and Developmental Biology at the University of Colorado Boulder and a Howard Hughes Medical Institute Investigator. She is known for her research identifying the factors and unraveling the mechanisms that determine the structure and dynamics of the largest organelle in the cell: the endoplasmic reticulum. Her lab has produced paradigm shifting studies on organelle membrane contact sites that have revealed that most cytoplasmic organelles are not isolated entities but are instead physically tethered to an interconnected ER membrane network.
Wendy Sarah Garrett is an American microbiologist who is the Irene Heinz Given Professor of Immunology and Infectious Diseases at the Harvard Chan School of Public Health. She holds a joint position in the Departments of Medicine at Harvard Medical School.